ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Diseases in which affected individuals may benefit from fertility preservation interventions

Diseases in which affected individuals may benefit from fertility preservation interventions
Malignant diseases
Childhood cancers*
Hodgkin and non-Hodgkin lymphoma
Ewing sarcoma
Pelvic osteosarcoma
Wilms tumor
Genital rhabdomyosarcoma
Burkitt lymphoma
Leukemia
Neuroblastoma
Adult cancers
Breast cancer
Infiltrative ductal
Stage I-III
Infiltrative lobular
Stage IV
Cancer of the cervix
Squamous cell carcinoma
Adeno-/adenosquamous carcinoma
Malignancies of the gastrointestinal tract
Autoimmune, hematologic, and metabolic diseases
Systemic lupus erythematosus
Behçet syndrome
Steroid-resistant glomerulonephritis
Rheumatoid arthritis
Inflammatory bowel disease
Progressive systemic sclerosis
Juvenile idiopathic arthritis
Multiple sclerosis
Pemphigus vulgaris
Autoimmune thrombocytopenia
Sickle cell disease
Aplastic anemia
Galactosemia 
Benign ovarian disease
Benign ovarian masses requiring radical surgery
Patients receiving pelvic radiation
Solid organ tumors presenting in the pelvis
Ewing's sarcoma
Osteosarcoma
Tumors of the spinal cord
Retroperitoneal sarcoma
Rectal cancer
Idiopathic bone disease requiring radiation
Prophylactic oophorectomy
BRCA I and II germline mutation carriers
Hematopoietic stem cell transplantation
Malignant diseases
Genetic, hematologic, and autoimmune disorders
* Cryopreservation of the ovarian tissue is the only option in children.
¶ If ovarian tissue is cryopreserved, ovarian metastases should be ruled out because of the moderate or high risk of ovarian involvement.
Modified with permission from: Sonmezer M, Shamonki MI, Oktay K. Ovarian tissue cryopreservation: benefits and risks. Cell Tissue Res 2005; 322:125. Copyright © 2005 Springer Verlag.
Graphic 60344 Version 9.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟